JETAX
Price
$14.92
Change
+$0.14 (+0.95%)
Updated
May 9 closing price
Net Assets
39.75M
RNPEX
Price
$62.30
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.32B
Ad is loading...

JETAX vs RNPEX

Header iconJETAX vs RNPEX Comparison
Open Charts JETAX vs RNPEXBanner chart's image
abrdn Focused Em Markets ex-China A
Price$14.92
Change+$0.14 (+0.95%)
VolumeN/A
Net Assets39.75M
American Funds New Perspective R4
Price$62.30
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.32B
JETAX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JETAX vs. RNPEX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JETAX is a Buy and RNPEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 142B vs. JETAX (39.7M). RNPEX pays higher dividends than JETAX: RNPEX (0.55) vs JETAX (0.00). JETAX was incepted earlier than RNPEX: JETAX (20 years) vs RNPEX (23 years). JETAX (1.94) is less costly to investors than RNPEX (0.76). JETAX is a more actively managed with annual turnover of: 49.00 vs. RNPEX (24.00). RNPEX has a lower initial minimum investment than JETAX: RNPEX (250) vs JETAX (1000). RNPEX annual gain was more profitable for investors over the last year : 5.27 vs. JETAX (0.54). RNPEX (46.39) and JETAX (44.44) have equivalent 5 years return.
JETAXRNPEXJETAX / RNPEX
Total Expense Ratio1.300.76171%
Annual Report Gross Expense Ratio1.940.76255%
Fund Existence20 years23 years-
Gain YTD4.8492.282212%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets39.7M142B0%
Annual Yield % from dividends0.000.55-
Returns for 1 year0.545.2710%
Returns for 3 years19.4027.4171%
Returns for 5 years44.4446.3996%
Returns for 10 years53.1064.0483%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN0.660.12
+21.87%
Alzamend Neuro Inc.
REPL7.71-0.06
-0.77%
Replimune Group
ASGN55.69-0.73
-1.29%
ASGN
TOI2.80-0.12
-4.11%
Oncology Institute (The)
AFRM46.41-7.85
-14.47%
Affirm Holdings